by ICLadmin | Apr 28, 2026 | Blog
In modern clinical development, imaging is not simply supportive data. Across oncology, neurology, cardiovascular, and musculoskeletal trials, imaging is frequently central to patient eligibility confirmation, treatment response evaluation, and endpoint assessment. In...
by ICLadmin | Apr 27, 2026 | Blog
Medical imaging in clinical trials is no longer a supportive diagnostic function. In 2026, it has become core clinical infrastructure directly influencing endpoint validation, regulatory submissions, medical device verification, and precision medicine strategy. As...
by ICLadmin | Jan 27, 2026 | Blog
Why Selecting the Right Annotation Tool Matters? High-quality image annotation is the foundation of accurate AI models in radiology. A mislabeled dataset doesn’t just reduce model accuracy; it risks regulatory delays, higher trial costs, and unreliable outcomes. ...
by ICLadmin | Jan 16, 2026 | Blog
Medical imaging plays a central role in clinical trials, from MRI tumor-response endpoints in oncology to PET biomarkers in neurology. As imaging becomes both a trial endpoint and a data source for secondary uses (e.g., AI algorithm development), sponsors and trial...
by ICLadmin | Aug 18, 2025 | Blog
Imaging plays a pivotal role in determining the progression and success of therapeutic development. It measures the safety, efficacy, and biological impact of new therapies. Imaging endpoints have become increasingly essential in therapeutic areas such as oncology,...
by ICLadmin | Feb 27, 2025 | Blog
Introduction: Why Imaging Data Matters Medical imaging plays a critical role in modern healthcare, serving as the foundation for accurate diagnosis, treatment planning, and disease monitoring. With advancements in artificial intelligence (AI) and big data analytics,...
